Aadi Bioscience, Inc. (AADI) Misses Q2 EPS by 12c

Aadi Bioscience, Inc. (NASDAQ: AADI) reported Q2 EPS of ($0.87), $0.12 worse than the analyst estimate of ($0.75). Revenue for the quarter came in at $3.4 million versus the consensus estimate of $2.75 million.

For earnings history and earnings-related data on Aadi Bioscience, Inc. (AADI) click here.

You May Also Be Interested In

• FedEx falls 4% as FY2027 profit forecast misses expectations despite Q4 beat
• Cerebras Systems posts 94% revenue jump, announces OpenAI deal
• Morgan Stanley upgrades CDW on stronger AI-driven server demand